MEDALLIANCE
Summary
MedAlliance is a developer of medical technology headquartered in Nyon, Switzerland. The company develops sirolimus micro-reservoir drug-coated balloon to treat patients suffering from peripheral artery disease (PAD), coronary artery disease (CAD), arteriovenous fistulas (AVF) and grafts (AVG) for end-stage renal disease.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 1.04 B
Avg. Deal Size£ 519 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
